Risk Assessment for Cancer-Associated VTE

Risk Assessment for Cancer-Associated VTE

Bibliographic Details
Main Author:	Alok A. Khorana, MD
Format:	Article
Language:	English
Published:	Elsevier 2021-09-01
Series:	JACC: Asia
Subjects:	malignancy prevention risk score thromboembolism
Online Access:	http://www.sciencedirect.com/science/article/pii/S2772374721000764

Similar Items

VTE risk assessment in pregnancy
by: Karl Ewins, et al.
Published: (2020-02-01)

Predicting VTE in Cancer Patients: Candidate Biomarkers and Risk Assessment Models
by: Silvia Riondino, et al.
Published: (2019-01-01)

Prediction of Major Bleeding in Anticoagulated Patients for Venous Thromboembolism: Comparison of the RIETE and the VTE-BLEED Scores
by: Ramón Lecumberri, et al.
Published: (2021-07-01)

Modified IMPROVE VTE Risk Score and Elevated D-Dimer Identify a High Venous Thromboembolism Risk in Acutely Ill Medical Population for Extended Thromboprophylaxis
by: Alex C. Spyropoulos, et al.
Published: (2020-01-01)

Evaluation of the predictive value of the bleeding prediction score VTE‐BLEED for recurrent venous thromboembolism
by: Frederikus A. Klok, et al.
Published: (2019-07-01)

Analysis of Influencing Factors for Postoperative Venous Thromboembolism  of Thymic Malignancies
by: Xingguo YANG, et al.
Published: (2021-07-01)

Genetic Risk Profiling Associated with Recurrent Unprovoked Venous Thromboembolism
by: Hossam Hodeib, et al.
Published: (2021-06-01)

Perioperative Venous Thromboembolism (VTE) Prophylaxis in Thoracic Cancer Patients: Chinese Experts Consensus - Interpretation of Application Prospect of Direct Oral Anticoagulant
by: Ruiheng JIANG, et al.
Published: (2019-12-01)

Effectiveness and safety of inpatient versus extended venous thromboembolism (VTE) prophylaxis with heparin following major pelvic surgery for malignancy: protocol for a systematic review
by: Bridget Heijkoop, et al.
Published: (2019-10-01)

The IMPROVEDD VTE Risk Score: Incorporation of D-Dimer into the IMPROVE Score to Improve Venous Thromboembolism Risk Stratification
by: C. Michael Gibson, et al.
Published: (2017-06-01)

Are we preventing VTE in patients with an infective exacerbation of chronic obstructive pulmonary disease - low adherence to VTE prophylaxis guidelines
by: Anmol Khanna
Published: (2016-12-01)

Perioperative Venous Thromboembolism (VTE) Prophylaxis in Thoracic Cancer Patients: Chinese Experts Consensus - Interpretation of Screening of High-risk Patients
by: Lihong LI, et al.
Published: (2019-12-01)

Validation of the Khorana Venous Thromboembolism Risk Score in Japanese Cancer Patients
by: Fumie Akasaka-Kihara, MD, et al.
Published: (2021-09-01)

Provoked versus unprovoked venous thromboembolism: Findings from GARFIELD‐VTE
by: Walter Ageno, et al.
Published: (2021-02-01)

What’s new in VTE risk and prevention in orthopedic surgery
by: Susan R. Kahn, et al.
Published: (2020-03-01)

Comparison of incidence/risk of venous thromboembolism (VTE) among selected clinical and hereditary risk markers: A community-based cohort study
by: Schramm Wolfgang, et al.
Published: (2005-07-01)

Risk Assessment Models of Venous Thromboembolism for Cancer Patients and Their Applications
by: HAN Sen, et al.
Published: (2020-11-01)

VTE Registry: What Can Be Learned from RIETE?
by: Inna Tzoran, et al.
Published: (2014-10-01)

Determination of Risk Factors for Venous Thromboembolism by an Adapted Caprini Scoring System in Surgical Patients
by: Bui My Hanh, et al.
Published: (2019-07-01)

Metabolomic Profile in Venous Thromboembolism (VTE)
by: Beata Franczyk, et al.
Published: (2021-07-01)

Pregnancy-Associated Venous Thromboembolism: Insights from GARFIELD-VTE
by: Carlos Jerjes-Sánchez, et al.
Published: (2021-01-01)

A novel algorithm to reduce VTE in peri-operative patients on tamoxifen
by: Alexi Nicola, MBBCh, MRCS, et al.
Published: (2021-08-01)

Preventing venous thromboembolism in oncology practice: Use of risk assessment and anticoagulation prophylaxis
by: Karlyn A. Martin, et al.
Published: (2020-10-01)

Evolving Treatment Options for Cancer-Related Venous Thromboembolism∗
by: Doaa Attia, MD, et al.
Published: (2020-09-01)

Predictive Ability of a Clinical-Genetic Risk Score for Venous Thromboembolism in Northern and Southern European Populations
by: Eduardo Salas, et al.
Published: (2021-07-01)

Anticoagulation Therapy for Venous Thromboembolism in the Real World ― From the COMMAND VTE Registry ―
by: Yamashita, Yugo
Published: (2019)

Perioperative Venous Thromboembolism (VTE) Prophylaxis in Thoracic Cancer Patients: Chinese Experts Consensus - Interpretation of Epidemiological Characteristics
by: Yixin SUN, et al.
Published: (2019-12-01)

Prevalence of venous thromboembolism risk factors and prophylactic adequacy among general surgical patients in a tertiary care hospital
by: Abin Chandrakumar, et al.
Published: (2016-07-01)

Venous Thromboembolism Prophylaxis and The International Medical Prevention Registry on Venous Thromboembolism (IMPROVE) Score in Medical Illness Patients
by: Dania Artriana Riswandi, et al.
Published: (2020-04-01)

Prevention of health care associated venous thromboembolism through implementing VTE prevention clinical practice guidelines in hospitalized medical patients: a systematic review and meta-analysis
by: Juliana Abboud, et al.
Published: (2020-06-01)

SPECIFICITY OF ANTICOAGULANT CHOICE FOR VTE PROPHYLAXES AFTER MAJOR ORTHOPEDIC SURGERY- THE VIEW OF CLINICAL PHARMACOLOGISTS
by: S. A. Bozhkova
Published: (2011-03-01)

Venous thromboembolic (VTE) prophylaxis in Cushing disease patients undergoing transsphenoidal surgery
by: Justin P. McCormick, et al.
Published: (2022-03-01)

Analysis of fatal outcomes from pulmonary thromboembolism in young subjects
by: O V Fesenko, et al.
Published: (2013-03-01)

Perioperative Venous Thromboembolism (VTE) Prophylaxis in Thoracic Cancer Patients: Chinese Experts Consensus - Interpretation of Perioperative Hypercoagulable State
by: Songping CUI, et al.
Published: (2019-12-01)

Validation of a Patient-Completed Caprini Risk Score for Venous Thromboembolism Risk Assessment
by: H. E. Fuentes, et al.
Published: (2017-07-01)

Cancer‐associated venous thromboembolism: Treatment and prevention with rivaroxaban
by: Rupert Bauersachs, et al.
Published: (2020-05-01)

Evaluating Risk of Recurrent Venous Thromboembolism During the Anticoagulation Period in Patients with Malignancy
by: Louzada, Martha
Published: (2011)

Evaluating Risk of Recurrent Venous Thromboembolism During the Anticoagulation Period in Patients with Malignancy
by: Louzada, Martha
Published: (2011)

Evaluating Risk of Recurrent Venous Thromboembolism During the Anticoagulation Period in Patients with Malignancy
by: Louzada, Martha
Published: (2011)

Evaluating Risk of Recurrent Venous Thromboembolism During the Anticoagulation Period in Patients with Malignancy
by: Louzada, Martha
Published: (2011)